Glutathione is your body's most important built-in antioxidant, the molecule your cells use to neutralize damage from normal metabolism. When that recycling system gets stressed or starts to falter, an intermediate called pyroglutamate (also called 5-oxoproline) tends to accumulate and spill into urine. Measuring it gives you a window into how hard your antioxidant machinery is working.
This is a research-tier marker, not a routine lab. Standardized clinical cutpoints do not yet exist for healthy adults, but elevated levels have been linked to autoimmune disease, oxidative stress in critical illness, chronic pain, and chronic acetaminophen use. A baseline gives you something to track as the science matures.
Pyroglutamate is a cyclized form of the amino acid glutamate. It sits inside the gamma-glutamyl cycle, the chemical loop your cells use to make and recycle glutathione. When glutathione production is overwhelmed or partially blocked, the loop backs up and pyroglutamate accumulates in tissues, blood, and urine.
This urine test measures pyroglutamate excretion. Because the kidney clears it efficiently, urinary levels reflect what your body is producing rather than what it is storing. Higher excretion generally signals that the glutathione recycling system is under more strain than usual.
Glutathione is the workhorse antioxidant inside almost every cell. It scavenges damaging molecules produced during normal metabolism, helps repair proteins and DNA, and supports detoxification by the liver. When demand for glutathione exceeds supply, the body shows it through metabolic side effects, and pyroglutamate is one of them.
In a retrospective analysis of 17,834 chronic pain patients, about 19% had elevated urinary pyroglutamate, interpreted as a sign of glutathione depletion. The same pattern shows up in critically ill people, in some autoimmune diseases, and in people on long-term acetaminophen, all situations where antioxidant capacity is being heavily taxed.
In a study of 123 people, those with systemic lupus erythematosus (an autoimmune disease often shortened to SLE) had higher serum L-pyroglutamic acid than healthy controls. The marker separated the two groups very accurately, catching about 97 out of 100 lupus cases while correctly clearing about 83 out of 100 healthy people. Higher levels also tracked with disease activity scores and inflammatory markers.
That study measured serum, not urine, so the same diagnostic accuracy has not been confirmed for urinary pyroglutamate specifically. Still, the finding suggests that the glutathione system is meaningfully disturbed in active autoimmunity, and that pyroglutamate is one of the clearest readouts of that disturbance.
In 28 people in intensive care with septic shock, both serum and urine pyroglutamate were higher than in healthy controls, and the elevation correlated with depletion of glutathione and signs of oxidative stress. A separate prospective study of 40 patients with high anion gap metabolic acidosis (a serious blood chemistry imbalance) found that pyroglutamate was a meaningful contributor in about 6% of cases, particularly in septic shock.
You will not be ordering this test mid-ICU stay. The relevance for a healthy adult is that the same pathway, glutathione recycling under stress, can be tracked in milder forms during everyday life, particularly in people whose bodies are chronically taxed by inflammation, illness, or heavy medication use.
Chronic pain is biologically expensive. The body produces more reactive oxygen molecules during ongoing inflammation, and the antioxidant system has to work harder. In the 17,834-patient chronic pain cohort, urinary pyroglutamate was used as part of a panel to flag people whose glutathione reserves were stretched thin.
Roughly one in five had elevated levels. The authors interpret this as a sign of reduced capacity to handle additional oxidative stress, including from medications like acetaminophen, which itself depletes glutathione. If you live with chronic pain or take a lot of acetaminophen, this marker can give you a sense of how the underlying chemistry is holding up.
At very high levels, pyroglutamate can drive a serious blood chemistry problem called high anion gap metabolic acidosis. The classic causes are an inherited enzyme deficiency (glutathione synthetase deficiency, usually identified in infancy) and an acquired form linked to chronic acetaminophen use, especially when combined with antibiotics like flucloxacillin and accompanied by malnutrition or sepsis.
For most adults ordering this test, that severe scenario is not what you are screening for. But the same biology applies in milder form: long-term high-dose acetaminophen use can deplete glutathione enough to push pyroglutamate up, even when the blood chemistry stays normal.
This is a Tier 3 research marker without universally agreed-upon cutpoints. Reference values come from the lab running the test and from research populations, not from a major guideline body. The single most useful rule is to compare your future readings to your own baseline using the same lab and the same method.
In the chronic pain study, about 19% of urine samples were classified as elevated against the lab's reference range. In the lupus study, serum levels above roughly 61.5 micromolar (a unit for very small concentrations in blood) flagged most lupus cases. Your urine result will be reported in different units and against a different range. Treat the lab's flag as a starting point, not a verdict.
| Tier | What It Suggests |
|---|---|
| Within lab reference range | Glutathione recycling appears to be keeping up with current demand. |
| Mildly above reference range | Possible early sign of glutathione strain. Worth retesting and reviewing acetaminophen use, sleep, and chronic stressors. |
| Substantially above reference range | Suggests meaningful glutathione depletion or oxidative stress. Pair with related tests and look for an underlying driver. |
A single pyroglutamate reading is most useful as the first point on a line. Levels can shift with illness, medication use, and chronic stress, and the marker has no universally validated decision threshold for healthy adults. What you can act on is the direction of change over time, especially after you change something that should affect glutathione status.
A reasonable cadence: get a baseline, retest in 3 to 6 months if you are making changes (cutting back on acetaminophen, addressing chronic inflammation, treating an autoimmune condition), and at least annually if you are tracking it as part of a broader oxidative stress picture. Use the same lab each time so the numbers are comparable.
An elevated pyroglutamate is a prompt to investigate, not a diagnosis on its own. The most useful next step is to look at the surrounding picture: your acetaminophen use, your inflammatory markers (hs-CRP, the high-sensitivity version of C-reactive protein), your kidney function, and any signs of an autoimmune process if you have symptoms.
If you take acetaminophen daily or near-daily, the simplest first move is to reduce that exposure and retest in a few months. If you have known autoimmune disease or chronic inflammation, share the result with the specialist managing that condition. If your pyroglutamate is high without an obvious explanation and you have unexplained fatigue, joint pain, or rashes, an autoimmune workup including ANA (a lupus screening test) is reasonable to discuss.
Evidence-backed interventions that affect your Pyroglutamate level
Pyroglutamate is best interpreted alongside these tests.